Jackman G P, McLean A J, Jennings G L, Bobik A
Clin Pharmacol Ther. 1981 Sep;30(3):291-6. doi: 10.1038/clpt.1981.162.
The plasma level: time profile for l-propranolol and total propranolol concentrations were examined in normotensive subjects after intravenous and oral dl-propranolol. l-Propranolol concentrations in plasma accounted for about 60% of total propranolol. This was attributed to lower volume of distribution for the isomer. Mean plasma clearance of 1-propranolol was similarly affected while apparent plasma half-life for the l-isomer and total propranolol were of the same order. Oral bioavailability of 1- and total propranolol averaged 40.7 +/- 8.5% and 42.4 +/- 12.9%. Food and hydralazine increased oral bioavailability of total and l-propranolol by similar magnitudes. We conclude that difference in the kinetics of l- and total propranolol concentrations in plasma are small and probably of no clinical significance. Presystemic clearance of propranolol in man does not appear to be stereospecific.
在正常血压受试者静脉注射和口服消旋普萘洛尔后,检测了左旋普萘洛尔和总普萘洛尔浓度的血浆水平:时间曲线。血浆中左旋普萘洛尔浓度约占总普萘洛尔的60%。这归因于该异构体的分布容积较低。左旋普萘洛尔的平均血浆清除率受到类似影响,而左旋异构体和总普萘洛尔的表观血浆半衰期处于同一数量级。左旋普萘洛尔和总普萘洛尔的口服生物利用度平均分别为40.7±8.5%和42.4±12.9%。食物和肼屈嗪使总普萘洛尔和左旋普萘洛尔的口服生物利用度提高的幅度相似。我们得出结论,血浆中左旋普萘洛尔和总普萘洛尔浓度的动力学差异很小,可能无临床意义。普萘洛尔在人体的首过清除似乎没有立体特异性。